Anticipating Advances in CAR T-Cell Therapies in Myeloma: Expert Discussion and Case Exploration

Get up to date on the latest developments in leveraging CAR T-cell therapies for multiple myeloma with downloadable slides and an on-demand webcast from an expert-led webinar.

Share

Program Content

CAR T in MM Overview
Overview of CAR T-Cell Therapy in Multiple Myeloma
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 22, 2023

Expires: February 21, 2024

View Activity
EP: CAR T for MM
ExpressPoints: Anticipating Advances in CAR T-Cell Therapies in Myeloma
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 22, 2023

Expires: February 21, 2024

View Activity
CAR T in MM Toxicities
Managing Acute and Long-term Toxicities With CAR T-Cell Products
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 22, 2023

Expires: February 21, 2024

View Activity
CAR T Advances in MM
Anticipating Advances in CAR T-Cell Therapies in Myeloma: Expert Discussion and Case Exploration
Video
Congratulations: You achieved a completion on 04/09/2022

Released: April 03, 2023

View Activity

Faculty

cover img faculity

Amrita Krishnan, MD, FACP

Director, Judy and Bernard Briskin Center for Multiple Myeloma Research
City of Hope
Duarte, California

cover img faculity

Nikhil Munshi, MD

Professor of Medicine
Harvard Medical School
Director of Basic and Correlative Science
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from

Bristol Myers Squibb

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC